Arix Bioscience Plc

Arix Bioscience (ARIX)

Company name:Arix Bioscience Plc
EPIC:ARIXTrading Currency:GBX
Market Sector:SQS3ISIN:GB00BD045071
Market Segment:SSQ3Share Type:DE
WWW Address: 0.001P
 Price Price Change [%] Bid Offer Open High Low Volume
 149.00 0.0 [0.00] 145.00 153.00 149.00 149.00 149.00 8,963
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 202.06 135.61 0.09 -53.80 - - - 172.50 - 58.50

Arix Bioscience Key Figures

(at previous day's close)
Market Cap.202.06m
Shares In Issue135.61m
Prev. Close149.00
PE Ratio- 
Dividend Yield-%
EPS - basic-53.80p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-6.25p
Return On Equity (ROE)-34.57%
Operating Margin-14,934.39%
PEG Factor- 
EPS Growth Rate-267.60%
Dividends PS Growth Rate-%
Net Debt-47.53m
Gross Gearing3.40%
Quick Assets55.74m
Net Working Capital48.91m
Intangibles / Fixed Assets0.67%
Turnover PS0.37p
Pre-Tax Profit PS-55.72p
Retained Profit PS-51.52p
Cash PS40.29p
Net Cash PS35.25p
Net Tangible Asset Value PS *148.28p
Net Asset Value PS149.04p
Spread8.00 (5.23%) 

Arix Bioscience Balance Sheet


Share Price Performance

Sample Period HighLow
1 week151.00149.00
4 weeks172.50105.00
12 weeks172.5078.00
1 year172.5058.50

Share Price Chart (5 years)

Arix Bioscience Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week151.00-2.00-1.32149.000.22149.11
4 weeks105.5043.5041.23105.000.15153.21
12 weeks78.5070.5089.8178.000.10130.00
26 weeks97.0052.0053.6173.000.07113.07
1 year103.5045.5043.9658.500.1098.64
3 years180.00-31.00-17.2258.500.08132.95
5 years210.00-61.00-29.0558.500.07140.74

Arix Bioscience Key Management Ratios

Arix Bioscience Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 0.83 
Tobin's Q Ratio (excl. intangibles)0.83 
Dividend Yield-%
Market-to-Book Ratio1.00 
Price-to-Pre-Tax Profit PS-2.67 
Price-to-Retained Profit PS-2.89 
Price-to-Cash Flow PS-23.85 
Price-to-Sales PS399.32 
Price-to-Net Tangible Asset Value PS1.00 
Price-to-Cash PS3.70 
Net Working Capital PS36.06 
Price Pct to Working Capital PS4.13%
Earnings Yield-%
Average PE5.19 
Years in average1 
PE to PE average-%

Arix Bioscience Financial Ratios

(Leverage Ratios)
Debt Ratio0.13%
Debt-to-Equity Ratio0.00 
Debt-to-Equity Ratio (excl. Intgbl)0.00 
Debt-to-Equity Market Value0.00 
Net Gearing-22.72%
Net Gearing (excl. Intangibles)-22.83%
Gross Gearing3.40%
Gross Gearing (excl. Intangibles)3.42%
Gearing Under 1 Year3.27%
Gearing Under 1 Year (excl. Intgbl)3.28%
(Liquidity Ratios)
Net Working Capital to Total Assets23.38%
Current Ratio8.15 
Quick Ratio (Acid Test)8.15 
Liquidity Ratio7.99 
Cash & Equiv/Current Assets98.02%
(Solvency Ratios)
Enterprise Value147.69m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.04 
Total Debt/Sales14.05 
Total Debt/Pre-Tax Profit-0.09 
Total Debt7.11m
Total Debt/Net Current Assets0.15%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs1 
Beta (60-Mnth)Beta (36-Mnth)

Arix Bioscience Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-37.34%
Return On Assets (ROA)-28.60%
Net Profit Margin-13,808.30%
Assets Turnover0.00 
Return On Equity (ROE)-34.57%
Return On Investment (ROI)-29.57%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-13,808.30%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.00 
Fixed Assets Turnover0.00 
Current Assets Turnover0.01 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales482.88 
Debt Collection Period1,183.00Days

Arix Bioscience Dividends

Sorry No Data Available

Arix Bioscience Fundamentals

 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
pre tax profit-9.53--7.69-414.11%42.763,219.95%-75.57-m
attributable profit-8.40--8.61-463.76%38.152,872.52%-69.87-m
retained profit-8.40--8.61-463.76%38.152,872.52%-69.87-m
eps - basic (p)-0.36 -0.11 32.10 -53.80 
eps - diluted (p)-0.36 -0.11 29.70 -53.80 
dividends per share- - - - 

Arix Bioscience Balance Sheet

 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
fixed assets fixed assets0.751.43%0.520.35%0.310.11%0.160.08%m
intangibles intangibles2.344.47%2.061.37%1.770.63%1.030.49%m
fixed investments fixed investments17.1232.66%71.3347.52%183.9865.84%152.2972.79%m
current assets - other current assets - other--%--%--%--%m
stocks stocks--%--%--%--%m
debtors debtors3.266.23%1.270.84%2.170.78%1.110.53%m
cash & securities cash & securities28.9355.21%74.9449.92%91.2232.64%54.6426.12%m
creditors - short creditors - short6.0711.59%3.672.44%9.283.32%6.843.27%m
creditors - long creditors - long--%--%--%0.270.13%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves46.3388.41%146.4497.56%270.1796.68%202.1196.60%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Arix Bioscience Cash Flow Statement

31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
Operating CF-13.63-8.78-11.06-8.47m
Pre-Financing CF-13.63-59.03-126.5025.66m
Retained CF28.9346.05-44.2524.68m

Arix Bioscience Brokers

Broker infomation is not available for this class of stock.
ADVFN Advertorial
Your Recent History
Arix Biosc..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20201201 05:23:24